Betta Pharmaceuticals Co (SZSE:300558) Long-Term Debt : ¥2,074 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Betta Pharmaceuticals Co Long-Term Debt?

Betta Pharmaceuticals Co's Long-Term Debt for the quarter that ended in Mar. 2024 was ¥2,074 Mil.

Betta Pharmaceuticals Co's quarterly Long-Term Debt increased from Sep. 2023 (¥1,733 Mil) to Dec. 2023 (¥1,816 Mil) and increased from Dec. 2023 (¥1,816 Mil) to Mar. 2024 (¥2,074 Mil).

Betta Pharmaceuticals Co's annual Long-Term Debt increased from Dec. 2021 (¥0 Mil) to Dec. 2022 (¥656 Mil) and increased from Dec. 2022 (¥656 Mil) to Dec. 2023 (¥1,816 Mil).

Betta Pharmaceuticals Co Long-Term Debt Historical Data

The historical data trend for Betta Pharmaceuticals Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Betta Pharmaceuticals Co Long-Term Debt Chart

Betta Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

280.00

656.03

1,816.00

Betta Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															1,676.03	1,914.03	1,733.20	1,816.00	2,074.49

Betta Pharmaceuticals Co (SZSE:300558) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Betta Pharmaceuticals Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Betta Pharmaceuticals Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Betta Pharmaceuticals Co (SZSE:300558) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Betta Pharmaceuticals Co Ltd (SZSE:300558) » Definitions » Long-Term Debt

Traded in Other Exchanges

N/A

Address

No.355, Xingzhong Road, Yuhang Economic and Technological Development Zone, Zhejiang Province, Hangzhou, CHN

Website

http://www.bettapharma.com

Betta Pharmaceuticals Co Ltd is a hi-tech pharmaceutical enterprise focuses on research and development of innovative medicines. The company's drug is used for various diseases such as malignant tumors, diabetes, and cardio-cerebrovascular disease. Further, it offers Icotinib hydrochloride, an orally administered small-molecule and a reversible tyrosine kinase inhibitor, which is used for the treatment of non-small-cell lung cancer. Geographically, the group operates through China.

Executives

Wang Jia Bing	Directors, executives
Ding Lie Ming	Directors, executives
Cai Wan Yu	Executives

Betta Pharmaceuticals Co (SZSE:300558) Headlines

No Headlines